Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FML 0.1% in Dry Eye Disease Exacerbation
NCT02051023Phase 3Completed
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluorometholone in dry eye disease (DED). Started Feb 2014; status: completed.
02
Drugs
fluorometholone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02051023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051023.